Compare TRGP & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TRGP | IQV |
|---|---|---|
| Founded | 2005 | 1982 |
| Country | United States | United States |
| Employees | N/A | 93000 |
| Industry | Natural Gas Distribution | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 57.7B | 35.1B |
| IPO Year | 2010 | 2013 |
| Metric | TRGP | IQV |
|---|---|---|
| Price | $295.05 | $259.87 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 14 | 16 |
| Target Price | ★ $257.29 | $227.13 |
| AVG Volume (30 Days) | 1.1M | ★ 1.2M |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | ★ 2.00% | N/A |
| EPS Growth | ★ 47.91 | 4.67 |
| EPS | ★ 5.75 | 1.61 |
| Revenue | ★ $17,028,300,000.00 | $9,739,000,000.00 |
| Revenue This Year | $30.33 | $6.77 |
| Revenue Next Year | $6.55 | $5.89 |
| P/E Ratio | ★ $51.18 | $161.00 |
| Revenue Growth | 3.95 | ★ 41.60 |
| 52 Week Low | $144.14 | $154.50 |
| 52 Week High | $307.94 | $271.80 |
| Indicator | TRGP | IQV |
|---|---|---|
| Relative Strength Index (RSI) | 58.07 | 62.56 |
| Support Level | $254.47 | $218.57 |
| Resistance Level | $307.94 | N/A |
| Average True Range (ATR) | 7.24 | 7.38 |
| MACD | -0.21 | -0.78 |
| Stochastic Oscillator | 45.89 | 67.41 |
Targa Resources Corp is a midstream firm that mainly operates gathering and processing assets with substantial positions in the Permian, Stack, Scoop, and Bakken plays. It has fractionation capacity at Mont Belvieu and operates a liquefied petroleum gas export terminal. The Grand Prix natural gas liquids pipeline is another important asset. It has two operating segments: Gathering and Processing, and, Logistics and Transportation (also referred to as the Downstream Business).
Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its research and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.